Eton Pharmaceuticals, Inc. ETON Other Commercial Liabilities
Other Commercial Liabilities at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s other commercial liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s other commercial liabilities?
- Eton Pharmaceuticals, Inc. (ETON) reported other commercial liabilities of $7.75M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s other commercial liabilities changed year-over-year?
- Eton Pharmaceuticals, Inc.'s other commercial liabilities increased by 2.7% year-over-year, from $7.54M to $7.75M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s other commercial liabilities?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s other commercial liabilities has grown at a 51.7% compound annual growth rate (CAGR), from $1.17M to $9.41M.